7 drug(s) with this reaction
9,125 total reports
Muscle Spasms has been reported as an adverse reaction across 7 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 9,125 adverse event reports mention muscle spasms in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with muscle spasms, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have muscle spasms listed in their FDA adverse event reports, sorted by report count:
In addition to muscle spasms, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
7 drug(s) manufactured by Amgen Inc have muscle spasms listed in their FDA adverse event reports: DENOSUMAB, Otezla, APREMILAST, ERENUMAB-AOOE, CINACALCET HYDROCHLORIDE, and others.
There are a combined 9,125 reports of muscle spasms across 7 Amgen Inc drug(s) in the FDA adverse event database.